The 19th Biosimilars Congregation 2024 is a congress that covers topics such as:
- Biosimilar development in emerging markets
- Current market trends and future challenges for Biosimilar success
- Commercial challenges and opportunities - strategies to develop Biosimilars
- Redesigning the Biosimilar business model: What is the optimum business model for Biosimilars?
- How do payers see Biosimilars and where is the market going?
- Leading Biosimilars companies share their views and strategies on successful market penetration and learn to implement best practices through recent successful strategies and business models – real time case studies
- Advances in Biosimilar clinical development and resulting regulatory challenges and opportunities
- Developing successful business models in Biosimilar product development
- Biosimilars development and impact on clinical practice
- Non-Clinical Studies in Biosimilars development
- Research-based industry Biosimilar strategies
- Capturing the mAb Biosimilar opportunity
- Considerations for the analytical similarity assessments when designing a Biosimilar development program
- Gain in-depth knowledge on role of technology transfer - How does this effect market access?
- Understanding the current regulatory approval standards for Biosimilars in Europe, US and ROI including for monoclonal antibodies
- Determining the right investments & potential returns from Biosimilars
The 19th Biosimilars Congregation 2024 brings together senior attendees with responsibilities in:
- Follow on Biologics/Follow on Proteins
- Biopharmaceuticals/ Biotherapeutics
- Legal Affairs
- Biologics/Biotechnology/ Biogenerics
- Health Economics
- Intellectual Property
- Clinical Immunology
- Pricing and Reimbursement
- Chief Scientific Officer
- Principal Scientist
- Analytical Characterisation
- Process Control and Analytical Technologies
- Pharmacovigilance
- Regulatory Compliance
- Quality Affairs/ Quality Control
- Drug Safety & Risk Management
- Process Science
- New Product Development
- Research & Development
- Portfolio Management
- Business Operations
- Business Development
- Commercial Affairs
- Scientific Affairs
The 19th Biosimilars Congregation 2024 will be held in Mumbai, India on 12 Dec 2024.